Results 141 to 150 of about 22,304 (253)

A falta de informação e os possíveis riscos sobre o uso exagerado da pílula do dia seguinte (levonorgestrel)

, 2021
Ana Cristina Lima Pêgo, Sabrina da Silva Chaves, Yolanda de Jesus Morais   +2 more
openalex   +2 more sources

Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time [PDF]

, 2007
Rami Stéphanie, Soraya Labied, Silvia Blacher, Françis Frankenne, Carine Munaut, Viviana Fridman, Aude Béliard, Jean Michel Foidart, Michelle Nisolle   +8 more
openalex   +1 more source

Efficacy and Outcomes of the Hormone-Releasing Levonorgestrel-Intrauterine System for Adenomyosis Treatment. [PDF]

Cureus
Pragash V, Khakhar A.
europepmc   +1 more source

Continuation of copper and levonorgestrel intrauterine devices: a retrospective cohort study [PDF]

, 2016
Sharon J. Phillips, Lisa G. Hofler, Anna M. Modest, Lara Harvey, Ligang Wu, Michele R. Hacker   +5 more
openalex   +1 more source

Vaginal Microbiota and Mucosal Pharmacokinetics of Tenofovir in Healthy Women Using a 90-Day Tenofovir/Levonorgestrel Vaginal Ring

, 2022
Andrea R. Thurman, Jacques Ravel, Pawel Gajer, Mark A. Marzinke, Louise A. Ouattara, Terry A. Jacot, M. Melissa Peet, Meredith R. Clark, Gustavo F. Doncel   +8 more
openalex   +1 more source

Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.

Gynecologic Oncology, 2018
Mie Jareid, J. Thalabard, Morten Aarflot, H. Bøvelstad, E. Lund, Tonje Braaten   +5 more
semanticscholar   +1 more source

A Study of the Effect of the Levonorgestrel Intrauterine System on the Management of Abnormal Uterine Bleeding. [PDF]

Cureus
Patil SS, Jadhav V, Pathak N.
europepmc   +1 more source

Venous thromboembolism in obese hormonal contraceptive users: a large national database study. [PDF]

Res Pract Thromb Haemost
Citla-Sridhar D, Rajpurkar M, Srivaths L, Bannow BS, Rosovsky RP, Sokkary N.   +5 more
europepmc   +1 more source

Efavirenz‐ but not nevirapine‐based antiretroviral therapy decreases exposure to the levonorgestrel released from a sub‐dermal contraceptive implant [PDF]

, 2014
Kimberly K. Scarsi, Mohammed Lamorde, Kristin M. Darin, Sujan Dilly Penchala, Laura Else, Shadia Nakalema, Pauline Byakika‐Kibwika, Saye Khoo, Susan E. Cohn, Concepta Merry, David Back   +10 more
openalex   +1 more source

The Levonorgestrel Intrauterine System Attenuates the Expression of Angiopoietin-1, Angiopoietin-2, and Vascular Endothelial Growth Factor in Adenomyosis. [PDF]

J Clin Med
Cho S, Kim HK, Choi YS, Park JH.
europepmc   +1 more source